Arcutis Biotherapeutics, Inc.
ARQT
21 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Mar 14 8:19 PM | Burnett Patrick | Proposed Sale | 12,242 | $15.04 | $184.1K | — | View → |
| Mar 4, 2025 | Mar 13 9:10 PM | Burnett Patrick | Proposed Sale | 49,161 | $14.98 | $736.4K | — | View → |
| Mar 4, 2025 | Mar 4 9:47 PM | Burnett Patrick | Proposed Sale | 954 | $13.28 | $12.7K | — | View → |
| Mar 4, 2025 | Mar 4 9:46 PM | Watanabe Todd Franklin | Proposed Sale | 4,135 | $13.28 | $54.9K | — | View → |
| Mar 3, 2025 | Mar 3 10:39 PM | Watanabe Todd Franklin | Proposed Sale | 20,880 | $13.03 | $272.1K | — | View → |
| Mar 3, 2025 | Mar 3 10:38 PM | Matsuda Masaru | Proposed Sale | 3,263 | $13.03 | $42.5K | — | View → |
| Mar 3, 2025 | Mar 3 10:36 PM | Burnett Patrick | Proposed Sale | 2,819 | $13.03 | $36.7K | — | View → |
| Mar 3, 2025 | Mar 3 9:50 PM | Welgus Howard G. | Proposed Sale | 10,000 | $13.00 | $130.0K | — | View → |
| Feb 3, 2025 | Feb 3 11:04 PM | Watanabe Todd Franklin | Proposed Sale | 19,301 | $12.70 | $245.1K | — | View → |
| Feb 3, 2025 | Feb 3 11:03 PM | Matsuda Masaru | Proposed Sale | 8,338 | $28.98 | $241.7K | — | View → |
| Feb 3, 2025 | Feb 3 11:02 PM | Edwards Larry Todd | Proposed Sale | 2,173 | $12.70 | $27.6K | — | View → |
| Feb 3, 2025 | Feb 3 11:01 PM | Burnett Patrick | Proposed Sale | 12,116 | $12.70 | $153.9K | — | View → |
| Feb 3, 2025 | Feb 3 10:10 PM | Welgus Howard G. | Proposed Sale | 10,000 | $12.71 | $127.1K | — | View → |
| Jan 2, 2025 | Jan 2 10:26 PM | Welgus Howard G. | Proposed Sale | 10,000 | $14.67 | $146.7K | — | View → |
| Dec 31, 2024 | Dec 31 9:19 PM | Burnett Patrick | Proposed Sale | 1,691 | $13.99 | $23.7K | — | View → |
| Dec 20, 2024 | Dec 20 10:02 PM | Watanabe Todd Franklin | Proposed Sale | 15,000 | $15.17 | $227.6K | — | View → |
| Dec 2, 2024 | Dec 2 9:25 PM | Welgus Howard G. | Proposed Sale | 10,000 | $12.51 | $125.1K | — | View → |
| Nov 22, 2024 | Nov 22 9:34 PM | Burnett Patrick | Proposed Sale | 16,023 | $10.14 | $162.5K | — | View → |
| Nov 19, 2024 | Nov 19 9:25 PM | Matsuda Masaru | Proposed Sale | 1,775 | $9.68 | $17.2K | — | View → |
| Nov 15, 2024 | Nov 15 9:31 PM | Burnett Patrick | Proposed Sale | 100 | $10.03 | $1.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 9:17 PM | Keith R LeonardDirector | Option Exercise | 39,272 | $8.63 | 0(D) | View → |
| Feb 27, 2026 | Mar 4 1:43 AM | Larry Todd EdwardsReporting Person's title: EVP, Chief Commercial Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Todd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer | Grant/Award | 266,000 | $26.97 | 266,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Grant/Award | 97,000 | $26.97 | 97,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Latha VairavanSVP Chief Financial Officer | Grant/Award | 70,000 | $26.97 | 70,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:41 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |